Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps.

Autor: Kühl Svoboda Baldin R; Group of Studies and Research in Tumor Markers, Faculdade Evangélica Mackenzie do Paraná, Curitiba, Brazil.; Department of Medical Pathology, Universidade Federal do Paraná, Curitiba, Brazil., Austrália Paredes Marcondes Ribas C; Group of Studies and Research in Tumor Markers, Faculdade Evangélica Mackenzie do Paraná, Curitiba, Brazil., de Noronha L; Department of Medical Pathology, Universidade Federal do Paraná, Curitiba, Brazil.; Group for Advanced Molecular Investigation, Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil., Veloso da Silva-Camargo CC; Group for Advanced Molecular Investigation, Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil., Santos Sotomaior V; Group for Advanced Molecular Investigation, Graduate Program in Health Sciences, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil., Martins Sebastião AP; Department of Medical Pathology, Universidade Federal do Paraná, Curitiba, Brazil., Vasconcelos de Castilho AP; Group of Studies and Research in Tumor Markers, Faculdade Evangélica Mackenzie do Paraná, Curitiba, Brazil., Rodrigues Montemor Netto M; Universidade Estadual de Ponta Grossa, Ponta Grossa, Brazil.
Jazyk: angličtina
Zdroj: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2021 Jul; Vol. 69 (7), pp. 437-449. Date of Electronic Publication: 2021 Jun 15.
DOI: 10.1369/00221554211026296
Abstrakt: Colorectal cancer can develop through molecular, chromosomal, and epigenetic cumulative changes that transform the normal intestinal epithelium into the colorectal polyps, called conventional adenomas (CAs) or serrated polyps (SPs), recognized as precursors of invasive colorectal neoplasia. These benign lesions need to explore the morphology, histological diagnosis, and biomarkers profile to accurately characterize lesions with potential for evolution to cancer. This study aimed to correlate the immunohistochemical expression of Parkin and Adenomatous Polyposis Coli (APC; tumor suppressors), Human Apurinic/Apyrimidinic endonuclease 1 (APE1), and B-cell lymphoma-extra-large (Bcl-xL; oncogenic proteins) in sporadic colorectal polyps with clinical, endoscopic, and diagnostic data. Immunohistochemical analysis was performed on tissue microarray samples of 306 polyps. Based on the Allred score, the expressions were graduated in the cytoplasm and nucleus of superficial and cryptic cells. There was higher Parkin nuclear expression ( p =0.006 and 0.010) and APC cytoplasmic expression in cryptic cells ( p <0.001) in SPs. CAs, APE1 ( p <0.001) and Bcl-xL ( p <0.001) were more expressed in the nuclei and cytoplasms, respectively. These results are related to the biological role proposed for these proteins in cellular functions. They can contribute to the diagnosis criteria for polyps and improve the knowledge of biomarkers that could predict cancer development.
Databáze: MEDLINE